Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin plus chloroquine for malaria prevention in pregnancy
NCT01103063Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Oct 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, open-label trial of azithromycin and chloroquine in Malaria (2 arms), sponsored by Pfizer. Primary endpoint: Percentage Participants With Sub-optimal Pregnancy Outcome. Started Oct 2010; status: terminated.
02
Drugs
azithromycinchloroquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT01103063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01103063.